SEC Company Response from InspireMD, Inc. (NSPR) (CIK 0001433607) (NSPR) — Feb 22, 2018
InspireMD, Inc. (NSPR) (CIK 0001433607)
Date: Feb. 22, 2018 · CIK: 0001433607 · Accession: 0001493152-18-002500
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-223130
Letter
InspireMD, Inc.
Menorat Hamaor. St.
Tel Aviv, Israel 6744832
(888) 776-6804
February 22, 2018
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street, NE
Washington, D.C. 20549
Attention: Tim Buchmiller
Re: InspireMD, Inc.
Registration Statement on Form S-3, filed on February 21, 2018
File No. 333-223130 (the “Registration Statement”)
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, InspireMD, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 4:00 p.m., Eastern Time, on February 23, 2018, or as soon thereafter as practicable.
In connection with the Company’s request for acceleration of the effective date of the Registration Statement, the Company acknowledges the following:
● should the U.S. Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
● the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
● the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.
Very
truly yours,
InspireMD,
Inc.
Show Raw Text
CORRESP
1
filename1.htm
InspireMD,
Inc.
4
Menorat Hamaor. St.
Tel
Aviv, Israel 6744832
(888)
776-6804
February
22, 2018
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, NE
Washington,
D.C. 20549
Attention:
Tim Buchmiller
Re:
InspireMD,
Inc.
Registration
Statement on Form S-3, filed on February 21, 2018
File
No. 333-223130 (the “Registration Statement”)
Ladies
and Gentlemen:
Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, InspireMD, Inc. (the “Company”)
hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective
at 4:00 p.m., Eastern Time, on February 23, 2018, or as soon thereafter as practicable.
In
connection with the Company’s request for acceleration of the effective date of the Registration Statement, the Company
acknowledges the following:
●
should
the U.S. Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to
delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect
to the filing;
●
the
action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not
relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
●
the
Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the
Commission or any person under the federal securities laws of the United States.
Should
any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel,
Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.
Very
truly yours,
InspireMD,
Inc.
By:
/s/
James Barry, Ph.D.
James
Barry, Ph.D.
Chief
Executive Officer